Abstract
Chloroquine (CQ) resistant vivax malaria is spreading. In this case, Plasmodium vivax infections during pregnancy and in the postpartum period were not satisfactorily cleared by CQ, despite adequate drug concentrations. A growth restricted infant was delivered. Poor susceptibility to CQ was confirmed in-vitro and molecular genotyping was strongly suggestive of true recrudescence of P. vivax. This is the first clinically and laboratory confirmed case of two high-grade CQ resistant vivax parasite strains from Thailand.
Original language | English |
---|---|
Pages (from-to) | 113 |
Journal | Malaria Journal |
Volume | 10 |
DOIs | |
Publication status | Published - 2011 |
Keywords
- Adult
- Antimalarials
- Chloroquine
- DNA, Protozoan
- Drug Resistance
- Female
- Genotype
- Humans
- Malaria, Vivax
- Parasitic Sensitivity Tests
- Plasmodium vivax
- Pregnancy
- Pregnancy Complications, Infectious
- Thailand
- Case Reports
- Journal Article
- Research Support, Non-U.S. Gov't